Cargando…
INFECTIOUS COMPLICATIONS AFTER TOCILIZUMAB IN PATIENTS WITH COVID: A REAL-WORLD EXPERIENCE
Autores principales: | LIU, HONGLI, NIU, CHENGU, ELKHAPERY, AHMED, ZHU, KAIWEN, G NAIR, LAKSHMI, IYER, CHAROO, ANJUM, ZAURAIZ, FAISAL, HAFSA, CHOW, MING-YAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548855/ http://dx.doi.org/10.1016/j.chest.2022.08.330 |
Ejemplares similares
-
Infectious Complications After Tocilizumab in Patients with COVID: A Real-World Experience
por: Liu, Hongli, et al.
Publicado: (2023) -
EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
por: FAIZAN, UNAIZA, et al.
Publicado: (2022) -
ACTIVE TB AFTER THE USE OF TOCILIZUMAB FOR COVID-19 INFECTION
por: NOH, SUNGRYONG, et al.
Publicado: (2021) -
PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022) -
PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)